MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03756cam a2200385 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
672285 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210307114523.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
950718s1996 nyua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
95033238 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0824793714 (alk. paper) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| Description conventions |
rda |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS200 |
| Item number |
.M63 1996 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1 |
| Edition number |
22 |
| Item number |
M. |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Modern pharmaceutics / |
| Statement of responsibility, etc |
edited by Gilbert S. Banker, Christopher T. Rhodes. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Third edition, revised and expanded. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
Marcel Dekker Inc., |
| Date of publication, distribution, etc |
[1996] |
| 264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc |
©1996 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
ix, 943 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
26 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Drugs and the pharmaceutical sciences ; |
| Volume number/sequential designation |
v. 72 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 1 Drug Products: Their Role in the Treatment of Disease, Their Quality, and Their Status and Future as Drug-Delivery Systems --<br/>chapter 2 Principles of Drug Absorption / Michael Mayersohn --<br/>chapter 3 Pharmacokinetics / David W. A. Bourne --<br/>chapter 4 Factors Influencing Drug Absorption and Drug Availability / Betty-ann Hoener and Leslie Z.Benet --<br/>chapter 5 The Effect of Route of Administration and Distribution on Drug Action / Svein Øie Leslie Z. Benet --<br/>chapter 6 Chemical Kinetics and Drug Stability / J. Keith Guillory Rolland I. Poust --<br/>chapter 7 Preformulation / Jens T. Carstensen --<br/>chapter 8 Cutaneous and Transdermal Delivery --<br/>Processes and Systems of Delivery / Gordon L. Flynn --<br/>chapter 9 Disperse Systems / Wandee Im-Emsap Ornlaksana Paeratakul Juergen Siepmann --<br/>chapter 10 Tablet Dosage Forms / Mary J. Kottke Edward M. Rudnic --<br/>chapter 11 Hard and Soft Shell Capsules / Larry L. Augsburger --<br/>chapter 12 Parenteral Products / James C. Boylan Steven L. Nail --<br/>chapter 13 Design and Evaluation of Ophthalmic Pharmaceutical Products --<br/>chapter 14 Delivery of Drugs by the Pulmonary Route / Anthony J. Hickey --<br/>chapter 15 Sustained- and Controlled-Release Drug-Delivery Systems --<br/>chapter 16 Target-Oriented Drug-Delivery Systems / Vijay Kumar Gilbert S. Banker --<br/>chapter 17 Packaging of Pharmaceutical Dosage Forms / Thomas J. Ambrosio --<br/>chapter 18 Optimization Techniques in Pharmaceutical Formulation and Processing / Joseph B.Schwartz, Robert E.O'Connor, and Roger L.Schnaare --<br/>chapter 19 Food and Drug Laws that Affect Drug Product Design, Manufacture, and Distribution --<br/>chapter 20 European Aspects of the Regulation of Drug Products with Particular Reference to Development Pharmaceutics --<br/>chapter 21 Pediatric and Geriatric Aspects of Pharmaceutics / Michelle Danish Mary Kathryn Kottke --<br/>chapter 22 Biotechnology-Based Pharmaceuticals / Paul R. Dal Monte S. Kathy Edmond Rouan Narendra B. Bam --<br/>chapter 23 The Pharmacist and Veterinary Pharmaceutical Dosage Forms / J. Patrick McDonnell Lisa Blair Banker --<br/>chapter 24 Dietary Supplements / Teresa Bailey Klepser --<br/>chapter 25 Bioequivalency / Christopher T. Rhodes --<br/>chapter 26 Drug Information / Hazel H. Seaba --<br/>chapter 27 Managed Care and Pharmacotherapy Management / Julie M. Ganther William R. Doucette --<br/>chapter 28 A View to the Future / Gilbert S. Banker Christopher T. Rhodes. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Dosage forms. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biopharmaceutics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacokinetics. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical industry |
| General subdivision |
Quality control. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Banker, Gilbert S., |
| Dates associated with a name |
1931-, |
| Relator term |
editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Rhodes, Christopher T., |
| Dates associated with a name |
1937-, |
| Relator term |
editor. |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ocip |
| f |
19 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |